blasts play a key role in fibrosis development in response to stress and injury. Angiotensin II (ANG II) is a major profibrotic activator whose downstream effects (such as phospholipase C␤ activation, cell proliferation, and extracellular matrix secretion) are mainly mediated via Gq-coupled AT1 receptors. Regulators of G protein signaling (RGS), which accelerate termination of G protein signaling, are expressed in the myocardium. Among them, RGS2 has emerged as an important player in modulating Gq-mediated hypertrophic remodeling in cardiac myocytes. To date, no information is available on RGS in cardiac fibroblasts. We tested the hypothesis that RGS2 is an important regulator of ANG II-induced signaling and function in ventricular fibroblasts. Using an in vitro model of fibroblast activation, we have demonstrated expression of several RGS isoforms, among which only RGS2 was transiently upregulated after short-term ANG II stimulation. Similar results were obtained in fibroblasts isolated from rat hearts after in vivo ANG II infusion via minipumps for 1 day. In contrast, prolonged ANG II stimulation (3-14 days) markedly downregulated RGS2 in vivo. To delineate the functional effects of RGS expression changes, we used gain-and loss-of-function approaches. Adenovirally infected RGS2 had a negative regulatory effect on ANG II-induced phospholipase C␤ activity, cell proliferation, and total collagen production, whereas RNA interference of endogenous RGS2 had opposite effects, despite the presence of several other RGS. Together, these data suggest that RGS2 is a functionally important negative regulator of ANG II-induced cardiac fibroblast responses that may play a role in ANG II-induced fibrosis development. collagen; cell proliferation; G proteins; myofibroblasts; phospholipase C␤ CARDIAC FIBROBLASTS are the most prevalent cell type in the myocardium (2, 38, 63) and play a central role in the maintenance of extracellular matrix (ECM) in the normal heart. Together with myocytes, they are key determinants of cardiac development, myocardial structure, cell signaling, and electromechanical function (3, 8, 48) . In response to stress and in the injured and failing heart, fibroblasts phenotypically transform into "activated" myofibroblasts with characteristic changes in gene expression, morphology, and function (33, 42, 55) . Myofibroblasts are the predominant cells responsible for collagen formation at sites of repair in the heart and fibrosis development (60), a major contributor to the cardiac remodeling response of the injured and diseased heart. Fibrosis can impair contractile function and electrical coupling of myocytes, which ultimately contribute to heart failure and predispose the heart to arrhythmias and sudden cardiac death, respectively (51).
CARDIAC FIBROBLASTS are the most prevalent cell type in the myocardium (2, 38, 63) and play a central role in the maintenance of extracellular matrix (ECM) in the normal heart. Together with myocytes, they are key determinants of cardiac development, myocardial structure, cell signaling, and electromechanical function (3, 8, 48) . In response to stress and in the injured and failing heart, fibroblasts phenotypically transform into "activated" myofibroblasts with characteristic changes in gene expression, morphology, and function (33, 42, 55) . Myofibroblasts are the predominant cells responsible for collagen formation at sites of repair in the heart and fibrosis development (60) , a major contributor to the cardiac remodeling response of the injured and diseased heart. Fibrosis can impair contractile function and electrical coupling of myocytes, which ultimately contribute to heart failure and predispose the heart to arrhythmias and sudden cardiac death, respectively (51) .
A key profibrotic activator of cardiac fibroblasts is angiotensin II (ANG II), which is produced by circulating and local renin-angiotensin-aldosterone systems that are upregulated in response to mechanical stretch and other cardiac insults (5, 26, 51, 59) . Adult rat cardiac fibroblasts express primarily AT 1 receptors (12, 58) : their stimulation activates G q -mediated phospholipase C␤ (PLC␤) (13) and induces secretion of collagen and other ECM proteins (6, 58) , transforming growth factor-␤ (TGF-␤) and other growth factors (10, 18, 32) , and cell proliferation (4) .
G q family members and other heterotrimeric GTP-binding proteins (G proteins) serve as central switch boards that transfer extracellular signals from G protein-coupled receptors across the plasma membrane to intracellular effectors and thereby determine signal transduction efficiency and specificity (39) . They are tightly controlled by regulators of G protein signaling (RGS) (25, 46) . The RGS family includes 20 canonical proteins that are grouped into four subfamilies based on primary sequence homology and the presence of additional domains (44, 67) . RGS share a conserved RGS core domain that is both necessary and sufficient to confer GTPase activity by binding directly to active, GTP-bound G␣ subunits (54) . This results in acceleration of G␣ GTPase activity and signal termination, as well as in some cases blocked G␣-mediated signal generation via effector antagonism (1, 22) . Each cell type expresses a unique RGS complement. RGS expression profiles are primarily based on Northern blots, in situ hybridizations, and PCR analyses, because antibodies that unequivocally recognize endogenous RGS isoforms at the protein level are generally not available. Several canonical RGS are expressed in the mammalian myocardium (36, 43) , as well as in cultured/isolated cardiac myocytes (14, 28) . To date, no information is available on RGS expression in cardiac fibroblasts.
In the cardiovascular system, RGS2 has emerged as a key player in regulating G protein signaling in cardiac myocytes and vascular smooth muscle cells (56) and plays an important role in modulating G q -mediated hypertrophy development (52, 66) and vascular tone (23, 53) . Like other members of the B/R4 subfamily, RGS2 mainly consists of the RGS core domain with short NH 2 -and COOH-terminal extensions. In contrast, RGS2 regulates G q proteins, whereas the others also target G i/o (21) . It has been proposed that RGS2 arose from the B/R4 subfamily to have specialized activity as a potent and selective G␣ q GTPase-activating protein that modulates cardiovascular function (31) . Importantly, RGS2 is highly regulated in its expres-sion in many cell types (30) , including cardiac myocytes (21) and vascular smooth muscle cells (19) .
This study was designed to determine whether RGS2 is expressed in cardiac fibroblasts, to investigate its regulation by ANG II, and to test the hypothesis that RGS2 is an important regulator of ANG II-induced signaling and function in cardiac fibroblasts. We have demonstrated that RGS2 1) is expressed at comparable levels in fibroblasts and activated myofibroblasts from adult rat ventricles, 2) is dynamically regulated by ANG II both in vitro and in vivo, and 3) exerts an inhibitory effect on ANG II-induced PLC␤ activity, collagen production, and cell proliferation. Moreover, we have identified several other RGS isoforms in cardiac fibroblasts that are not changed in their expression by ANG II. After 20 min, the ventricular tissue was isolated, minced, and further digested at 37°C for 18 min in enzyme buffer 1 supplemented with increased CaCl 2 (500 M), trypsin IX (0.6 mg/ml; Sigma), and deoxyribonuclease (0.6 mg/ml; Sigma). The cell suspension was then filtered into 10 ml of DMEM/F12 (Invitrogen, Carlsbad, CA) with 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin (complete medium) and centrifuged for 2 min at 20 g. The supernatant was removed from the pelleted myocytes and centrifuged again for 5 min at 800 g. The resulting fibroblast pellet was resuspended in complete medium and plated for 2 h, after which the medium was changed to remove unattached or loosely attached cells, including vascular smooth muscle cells, endothelial cells, and a few remaining myocytes. Originally plated cells (P0) and the first two passages (P1 and P2, each obtained by trypsinization after 3 days in complete medium) were used in this study. Experiments in each passage were performed in six-well plates. Cells were maintained in complete medium until they were subjected to specific conditions described for each experiment. DMEM/F12 supplemented with 10 g/ml insulin, 5.5 g/ml transferrin, and 5 ng/ml sodium selenite (ITS; Sigma) was used as serum-free medium when indicated.
MATERIALS AND METHODS

Isolation
Immunofluorescent staining. Fibroblasts plated on coverslips were maintained in complete medium for 72 h, fixed with 4% formaldehyde, and permeabilized with 0.1% Triton X-100 in PBS [15 min at room temperature (RT) each]. Nonspecific binding sites were blocked with Image-IT FX signal enhancer (Invitrogen; 30 min at RT), followed by incubation (1 h at RT) with antibodies against vimentin (Sigma; 1:100), ␣-smooth muscle actin (␣-SMA; Sigma; 1:400), the embryonic form of smooth muscle myosin heavy chain ( (35) . Each sample was assayed in triplicate.
Reverse transcription-PCR. Total RNA (1 g) extracted from fibroblasts was reverse transcribed and amplified using the SuperScript One-Step RT-PCR kit (Invitrogen) with RGS isoform-specific primers (Table 1) . One-Step RT-PCR was performed at 50°C for 30 min and 94°C for 2 min and then at 94°C for 30 s, 48 -56°C for 30 s, and 72°C for 1 min for a total of 30 -40 cycles, followed by 72°C for 5 min. RT-PCR products were visualized on ethidium bromidestained agarose gels. RNA from adult rat cortex and adult ventricular myocytes were used for control and comparison, respectively.
Real-time PCR. Reverse-transcribed (TaqMan reverse transcription reagents) RNA samples from fibroblasts were subjected to real-time PCR using FAM-labeled TaqMan probes for RGS2, RGS3, RGS5, GAPDH, and 18S and universal PCR master mix according to the manufacturer's instructions (Applied Biosystems, Carlsbad, CA). Each sample was assayed in duplicate in two independent PCR reactions and normalized to 18S expression. Samples without enzyme in the reverse transcription reaction or template during PCR served as negative controls. PCR cycling was performed at 95°C for 10 min, followed by 95°C for 15 s and 60°C for 1 min for a total of 40 cycles using ABI Prism 7500. The cycle threshold (CT) values corresponding to the PCR cycle number at which fluorescence emission in real time reaches a threshold above the baseline emission were determined using sequence detecting system software (SDS version 1.4; Applied Biosystems). Serial dilutions of cDNA plasmids for rat RGS2 and RGS5 (0.3-3 ϫ 10 6 copies) confirmed the linearity of the resulting CT values.
Adenoviral gene transfer. Adenovirus encoding NH2-terminally FLAG-tagged RGS2 (Ad-RGS2) was generated previously (21) . Control adenovirus (Ad-Ctr) and a green fluorescent protein (GFP)-expressing adenovirus (Ad-GFP) served as controls. Fibroblasts were cultured in complete medium and infected the next day. To ensure comparable multiplicity of infection (MOI) between passages with different growth rates, a representative well was trypsinized and counted. Appropriate amounts of adenovirus in DMEM/F12 containing 0.5 ml of ITS were then added to each well immediately after medium aspiration. Complete medium was added (1.5 ml) after 2 h.
RNA interference. The short interfering RNA (siRNA) for RGS2 was previously generated with AAGGAAAATATACACCGACTT as target sequence (66) . GAPDH siRNA and negative control siRNA without significant homology to any known rat gene (Applied Biosystems) served as controls. After optimization of the type/amount of transfection reagent and siRNA, the following conditions were determined to achieve effective gene suppression with a minimum amount of siRNA. Fibroblasts were cultured in complete medium and subjected to RNA interference (RNAi) the next day using siPORT amine transfection agent diluted in OPTI-MEM (Invitrogen). After 10 min of incubation at RT, 75 nM siRNA was added and incubated for another 10 min. The siRNA/siPORT amine transfection complexes were then dispensed onto the cells right after medium change with antibioticfree DMEM/F12 containing 2% FBS (2 ml/well). Cellular siRNA uptake was visualized by fluorescent microscopy 2 days after transfection of Cy3-labeled siRNA (Applied Biosystems).
Total collagen assay. After 20 h in serum-free medium, fibroblasts were incubated in ANG II (1 M) for 48 h, lysed as described above, and sonicated for 3 ϫ 5 s on ice. After centrifugation at 3,000 g, total collagen content was assayed in equal amounts of supernatant according to the manufacturer's instructions for the Sircol soluble collagen assay kit (Biocolor, Carrickfergus, County Antrim, UK). Briefly, supernatants were mixed with Sircol dye reagent for 30 min at RT. After centrifugation at 15,000 g for 10 min, the collagen-Sircol dye complex was precipitated, unbound dye was removed with the supernatant, and collagen-bound dye was subsequently released and quantitated via spectrophotometry at 540 nm. Normalization to protein concentrations gave similar results.
Cell proliferation. Fibroblasts were cultured on coverslips and starved in serum-free medium for 20 h. Bromodeoxyuridine (BrdU; 30 nM) was added immediately before addition of ANG II (1 M). After 48 h, cells were fixed in 4% formaldehyde and incorporated BrdU was identified with a mouse anti-BrdU antibody (Dako, Carpinteria, CA; 1:100) and Alexa Fluor 594-conjugated secondary antibody (Invitrogen; 1:200). Coverslips were mounted as described above. Experiments were done in triplicate, and five images (with 300 -400 cells) were taken randomly for each coverslip. Fibroblast proliferation was expressed as the percentage of BrdU-positive nuclei to DAPIpositive (total) nuclei.
Chronic ANG II infusion model. Male Sprague-Dawley rats (5-6 wk old) were anesthetized with ketamine and medetomidine (75 and 1 mg/kg body wt). Osmotic minipumps (Alzet, Cupertino, CA; models 1003D, 2001, or 2002) were used and primed in sterile 0.9% saline at 37°C overnight to ensure immediate delivery of ANG II (555 ng·kg Ϫ1 ·min Ϫ1 ) or 0.9% saline after subcutaneous implantation. After surgery, the animals received regular chow with 0.4% KCl in drinking water. At the indicated time points (5 h to 2 wk), hearts were removed for isolation of ventricular fibroblasts and myocytes to investigate the RGS2 expression or processed for histology.
Gomori trichrome stain. Cross sections (5 m) of formalin-fixed and paraffin-embedded hearts were deparaffinized in xylene, rehydrated through ethanol gradient solutions to PBS, and treated with Bouin's solution (Sigma). They were then stained with Weigert's iron hematoxylin (Electron Microscopy Sciences, Hatfield, PA) for 10 min, followed by trichrome stain for 20 min. After dehydration, slides were mounted with SHUR/Mount toluene-based mounting medium (Triangle Biomedical Sciences, Durham, NC).
Statistical analysis. Data from representative assays are shown and expressed as means Ϯ SD for n determinations (unless indicated otherwise). Statistical differences were assessed using unpaired twotailed Student's t-test or two-way ANOVA for comparison of individual means. A P value Ͻ0.05 was considered statistically significant.
RESULTS
In vitro model of cardiac fibroblasts and myofibroblasts.
In response to stress, cardiac fibroblasts undergo three phenotypic changes: they convert into activated (i.e., contractile and hypersecretory) myofibroblasts, proliferate, and produce ECM components (such as collagen I and III) (42, 55) . In this study, we used the first three passages (P0 -P2) of ventricular fibroblasts isolated from 5-wk-old rats under experimental conditions that mimic these changes.
First, we determined the purity of the cell preparations: cells in all three passages expressed vimentin at comparable levels ( Fig.  1, A and B) but were negative for smooth muscle myosin and vWF, indicating the absence of vascular smooth muscle cells and endothelial cells, respectively (Fig. 1A) . Cardiac myocytes, which can be easily identified by their rod shape, were also not present. Using surrogate markers for myofibroblasts (15, 33, 55) , we delineated the timing and extent of phenotypic changes of fibroblast across the three passages: ␣-SMA and the embryonic form of smooth muscle myosin heavy chain were expressed at very low levels in P0 cells and markedly increased in P1 and P2 fibroblasts (Fig. 1, A and B) . P1/P2 cells were also significantly larger and contained an increasing amount of ␣-SMApositive stress fibers (Fig. 1A) , suggesting progressive transformation of fibroblasts into activated myofibroblasts from P0 to P1/P2. Consistent with this notion, cell numbers (Fig. 1C) and procollagen type I expression (Fig. 1D) were increased in P1 and P2 compared with P0. Total IP formation normalized to cell numbers in each passage was measured as a reflection of PLC␤ activity: both basal and ANG II-induced PLC␤ activity showed a gradual increase from P0 to P2 (Fig. 1E) . Thus the first three passages of freshly isolated adult ventricular fibroblasts recapitulate key phenotypic features of fibroblasts (P0) and myofibroblasts (P1/P2).
Transient RGS2 upregulation in response to short-term ANG II stimulation. Using RT-PCR, we found that RGS2 is expressed in cardiac fibroblasts ( Fig. 2A) . Its mRNA level was comparable to that of myocytes (isolated from the same heart) and brain and was not significantly changed between cell passages. In response to short-term stimulation with ANG II, RGS2 mRNA was transiently upregulated as shown by realtime PCR (Fig. 2B) . Of note, TGF-␤, which is enhanced in its expression by ANG II (29) , also increased RGS2 expression (see Supplemental Fig. S1 for 6-h stimulation; supplemental material for this article is available online at the American Journal of Physiology-Heart and Circulatory Physiology website), and its effect was transient within 24 h (data not shown). Both ANG II and TGF-␤ effects were more pronounced in P0 than in P1 and P2.
We asked whether other RGS are expressed and regulated by ANG II. Figure 2Ca shows that members of all four canonical RGS subfamilies are expressed in cardiac fibroblasts. Depending on the isoform but unrelated to the subfamily, their expression was equal (RGS3), higher (RGS8, RGS10, RGS11, RGS17, RGS18, RGS20), or lower (RGS5 and RGS7) than in myocytes. Importantly, in contrast to RGS2, the other RGS were not altered in response to ANG II stimulation ( Fig. 2Cb ; see also Fig. 2B for RGS5) .
Transient upregulation of RGS2 was also observed in cardiac fibroblasts that were freshly isolated from rats that had been subjected to subcutaneous ANG II infusion in vivo for less than 2 days (Fig. 2D ). These findings demonstrate the presence of RGS2 mRNA in cardiac fibroblasts at a level comparable to that in myocytes and selective transient RGS2 upregulation in response to short-term ANG II stimulation both in vitro and in vivo.
Selective RGS2 downregulation in response to prolonged ANG II stimulation. The in vivo model provided an opportunity to also investigate the effect of prolonged ANG II stimulation on RGS2 mRNA expression levels. After the transient rise within a day of subcutaneous ANG II infusion (see above), RGS2 was markedly downregulated as early as 3 days after ANG II pump insertion and until at least 14 days (end of study) (Fig. 3A) . We Fig. 3 . Selective RGS2 downregulation in response to prolonged ANG II stimulation in vivo. A: real-time PCR analysis of RGS2 expression in freshly isolated cardiac fibroblasts from rats subjected to subcutaneous ANG II infusion (555 ng·kg Ϫ1 ·min
Ϫ1
) for the indicated days (n ϭ 3 each). *P Ͻ 0.05, ANG II vs. vehicle. B: RT-PCR analysis of RGS2 and other RGS (organized according to their subfamily affiliations) in freshly isolated cardiac fibroblasts from rats subjected to subcutaneous ANG II infusion for 7 days. ␤-Actin was used as internal control. also observed RGS2 downregulation in cardiac myocytes after prolonged ANG II stimulation in vivo (64 Ϯ 12% of vehicle control after 3 days, P Ͻ 0.05; 67 Ϯ 29% of vehicle control after 14 days, P ϭ 0.18; n ϭ 3 each), which followed transient RGS2 upregulation (2.2 Ϯ 0.5 fold, n ϭ 6, P Ͻ 0.05) after 18 h of ANG II stimulation.
We excluded the possibility that ANG II may be degraded over time by demonstrating that the efficacy in activating PLC␤ activity in cultured fibroblasts (P2 cells) was comparable between ANG II that was extracted from the minipumps 5 days after insertion and ANG II that was freshly prepared on the day of the assay [1,697 Ϯ 141 vs. 1,635 Ϯ 56 counts per minute per 6 wells (cpm/6 wells), n ϭ 3 each, not significant; basal 305 Ϯ 14 cpm/6 wells]. Proper drug release was also confirmed. Subsequently, for the 2-wk time point, pumps were exchanged twice after 5 days each.
In contrast to RGS2, the other RGS isoforms were not altered, as shown for the 7-day time point in Fig. 3B . As expected, ANG II infusion for 2 wk induced cardiac hypertrophy (Supplemental Fig. S2A ), indicated by an increase in ventricular weight/body weight and expression of atrial natriuretic factor and by interstitial and perivascular fibrosis (Supplemental Fig. S2B ). Matrix metalloproteinase (MMP)-2, MMP-9, and MMP-13 mRNA levels were unchanged (Supplemental Fig. S2C ), but altered activity cannot be excluded.
RGS2 overexpression inhibits ANG II-induced effects in cardiac fibroblasts.
To investigate the functional effects of increased RGS2 expression, we overexpressed RGS2 in P0 -P2 cells via adenoviral gene transfer. We did not observe any apparent changes in cell morphology or viability after adenoviral gene transfer with different MOIs (MOIs 1, 3, and 10; data not shown). As expected, the infection efficiency in fibroblasts was dependent on the MOI, as shown with Ad-GFP for P1 cells in Supplemental Fig. S3A (similar results were obtained in P0 and P2). Accordingly, FLAG-tagged RGS2 protein expression could be titrated (Fig. 4A) . The characteristic ANG II-induced rise in IP formation in cells infected with Ad-Ctr was dose-dependently inhibited on Ad-RGS2 infection at MOIs 1, 3, and 10 (shown for P1 cells in Supplemental Fig.  S3B, top) . At MOI 10, RGS2 inhibited IP formation by 65-75% in all three passages (Supplemental Fig. S3B, bottom) .
RGS2 expression negatively regulated ANG II-induced PLC␤ activity, total collagen production, and cell proliferation in adult ventricular fibroblasts: the ANG II-induced rise in IP formation was reduced from 4.8-fold in Ad-RGS2-infected cells to 2.6-fold in control cells (Fig. 4B, top) . Similarly, a 2.1-fold rise in total collagen production in response to ANG II stimulation was reduced to 1.3-fold over basal in Ad-RGS2-infected cells (Fig. 4B, middle) , and a 1.9-fold rise in BrdU incorporation was inhibited to 1.4-fold (Fig. 4B, bottom) . RGS2 had no significant effect on basal PLC␤ activity, total collagen production, or cell proliferation.
RGS2 knockdown enhances ANG II-induced effects in cardiac fibroblasts. We used RNAi to examine the functional consequences of downregulation of endogenous RGS2. Phasecontrast and fluorescent images of fibroblasts transfected with Cy3-labeled siRNA show uniform cellular siRNA uptake that was detectable in more than 95% of cells, with no apparent changes in cell viability or morphology (Supplemental Fig.  S4A ). Compared with cells transfected with negative control siRNA, we were able to achieve up to 80% reduction in GAPDH mRNA (Supplemental Fig. S4B ) and up to 60% reduction in RGS2 mRNA (Fig. 5A ) using gene-specific siRNAs. Importantly, mRNA expression of other isoforms such as RGS5 (Fig. 5A ) and RGS3 (data not shown) was not changed in cells transfected with RGS2 siRNA.
Selective reduction in RGS2 expression markedly enhanced ANG II-induced PLC␤ activity, cell proliferation, and total collagen production: G q -mediated IP formation over basal was increased from 4.5-fold in control cells to 11.4-fold in RGS2 siRNA-transfected cells (Fig. 5B, top) . In addition, RGS2 RNAi increased ANG II-induced total collagen production ( Fig. 5B, middle) and fibroblast proliferation (Fig. 5B, bottom ) from 1.2-and 1.8-fold in control cells to 1.6-and 2.7-fold in RGS2 siRNA-transfected cells, respectively. RGS2 RNAi had no significant effect on basal PLC␤ activity, total collagen production, or cell proliferation.
DISCUSSION
ANG II is a well known profibrotic factor in many mammalian species, including humans (29) . The majority of downstream effects are mediated via G q -coupled AT 1 receptors. RGS2 is an important regulator of G q signaling in cardiac myocytes; however, no information is available for cardiac fibroblasts. We therefore investigated RGS2 expression, regulation, and function, using rat ventricular fibroblasts and myofibroblasts in the presence or absence of ANG II in vitro, as well as ANG II infusion in vivo, combined with molecular gain-and loss-of-function approaches. We have demonstrated that RGS2 expression is uniquely susceptible to ANG IIinduced dynamic and biphasic regulation in vitro and in vivo and have shown that RGS2 is a functionally important negative regulator of ANG II-induced signaling and functional effects in cardiac fibroblasts despite the presence of several other RGS.
Experimental models. Primary isolates of fibroblasts from the heart and other organs are widely used to study their signaling properties and cellular functions under defined experimental conditions. The purity of the cell preparations for our in vitro model was confirmed by positive staining for vimentin and the absence of staining for endothelial cells and vascular smooth muscle cell markers. The first three passages represent different fibroblast phenotypes ( Fig. 1) : consistent with two other reports (16, 34) , P0 cells that had a fibroblastlike appearance gradually converted into myofibroblast-like phenotype after plating at 200 cells/mm 2 and dual passage for 3 days each in complete medium, as evidenced by expression of smooth muscle cell markers (␣-SMA and embryonic form of smooth muscle myosin heavy chain) and the presence of stress fibers (24) . In addition, P1 and P2 cells increased in number more than P0 cells and had increased procollagen type I expression as well as basal and ANG II-stimulated PLC␤ activity, which is consistent with a myofibroblast phenotype.
Myofibroblasts are typically not found in normal cardiac tissue but appear at sites of tissue repair (33) . In contrast to other tissues, they persist in the myocardium long after the injury (61) . The origin of myofibroblasts in the heart is still a matter of debate (64) . Suspected sources include resident fibroblasts (62) , endothelial cells (65) , and bone marrowderived hematopoietic precursor cells (17, 57) . Our observations support the conventional view that resident fibroblasts in the heart can transform into myofibroblasts and suggest that circulating precursor cells may not be an absolute requirement. However, cell fate mapping studies are needed to determine the role of resident fibroblasts as source for activated myofibroblasts in vivo (64) .
Subcutaneous ANG II infusion via osmotic minipumps was used to determine whether effects in vitro could also be observed in vivo. Moreover, it enabled us examine the effects of prolonged ANG II stimulation. This in vivo model has been used widely in the literature to investigate cardiac remodeling with ANG II delivery rates from 150 to 1,000 ng·kg Ϫ1 ·min Ϫ1 in rodents (4, 9) . We chose 555·kg
Ϫ1 ·min Ϫ1 for this study, as previously described (50) , because in male Sprague-Dawley rats infused with ANG II at 500 ng·kg Ϫ1 ·min Ϫ1 , plasma ANG II levels were shown to increase 6-fold compared with controls (11) , which is in the same range (7-fold increase) as seen in heart failure patients (40) . Consistent with other reports (27, 49, 50) , ANG II infusion induced interstitial and perivascular fibrosis in the myocardium, as well as cardiac hypertrophy (Supplemental Fig. S2) .
RGS2 expression and regulation in cardiac fibroblasts. In the present study, we demonstrated both in vitro and in vivo that RGS2 is transiently upregulated in fibroblasts and myofibroblasts in response to short-term ANG II stimulation (Fig. 2) . TGF-␤ had a similar effect in vitro (Supplemental Fig. S1 ). Importantly, on prolonged ANG II infusion in vivo, we observed marked RGS2 downregulation in cardiac fibroblasts (Fig. 3) . A similar biphasic regulation of RGS2 was also observed in cardiomyocytes from the same hearts, consistent with previous studies on RGS2 regulation in cardiac myocytes in response to short-term and prolonged activation of the G q signaling pathway (21, 68) . Ascending aortic constriction also leads to marked RGS2 downregulation in ventricular tissues, but cell type-specific RGS2 expression was not examined (66) .
Further work is needed to determine the mechanisms for the observed biphasic RGS2 regulation in cardiac fibroblasts on ANG II stimulation. Our data suggest that TGF-␤ may be involved. Reports in other cell types suggest that protein kinase C (PKC)-and Ca 2ϩ -dependent mechanisms participate in RGS2 upregulation after acute stimulation of the G q signaling pathway (30, 47) . Much less is known about the mechanisms of RGS2 downregulation. Prolonged activation of PKC can lead to its downregulation, thereby potentially reducing a stimulus for RGS2 expression. However, possible contributions of this and/or other mechanisms to the downregulation of RGS2 expression have yet to be elucidated and were beyond the scope of this study.
RGS2 function in cardiac fibroblasts. It is well known that enhanced G q -mediated signal transduction in fibroblasts leads to an increase in cell proliferation and total collagen production, both of which are profibrotic effects (5). Expression of exogenous RGS2 was sufficient to inhibit ANG II-induced PLC␤ activity, fibroblast proliferation, and total collagen production (Fig. 4) . Conversely, knockdown of endogenous RGS2 markedly increased all three parameters (Fig. 5) , indicating that endogenous RGS2 exerts important inhibitory effects despite the unperturbed presence of other RGS with potentially overlapping function (see below).
Given that RGS2 is a potent negative regulator of G q in many cell types, RGS2 upregulation in response to short-term increase in G q signaling is generally viewed as a negative feedback mechanism (30) . In this study, it was more pronounced in nonactivated fibroblasts (P0) than in myofibroblasts (P1/P2), suggesting less negative regulation of G q signaling by RGS2 in myofibroblasts under short-term ANG II stimulation.
The extent of RGS2 down-regulation after prolonged ANG II infusion (42-58% reduction) was comparable to what we achieved by RNAi in vitro (59% reduction). Functionally, fibroblasts in vitro responded with enhanced profibrotic ANG II effects on cell proliferation and total collagen production, suggesting that RGS2 may play a role in exacerbating fibrosis development in the stressed or injured heart with enhanced ANG II stimulation (see also below). Further investigations are needed to evaluate the role of RGS2 in regulating collagen production and/or degradation. Importantly, RGS2 downregulation in cardiac myocytes in response to enhanced G q signaling has been implicated to increase the hypertrophic response in vitro (66) and in vivo (52) . Thus the extent and timing of RGS2 regulation appears to play a role in both aspects of the cardiac remodeling response to stress.
Other RGS in cardiac fibroblasts. To our knowledge, this is the first demonstration of canonical RGS expression in cardiac fibroblasts. We report expression of members of each subfamily in cardiac fibroblasts, which differed substantially from cardiac myocytes. In addition, several isoforms appeared to be altered in their expression during fibroblast-to-myofibroblast transformation in vitro (see basal conditions in Fig. 2C ). For example, RGS11, RGS18, and RGS20 were decreased, whereas RGS7 and RGS17 were increased. Much work needs to be done to delineate the functional role of each RGS isoform in cardiac fibroblasts and myofibroblasts both in vitro and in vivo.
Although the A/RZ and C/R7 subfamily members expressed are selective for G␣ i/o proteins, all B/R4 members accelerate GTPase activity for G␣ q proteins (46) . In addition, RGS10 (D/R12) was shown to regulate G q signaling (45) . The fact that selective RGS2 downregulation led to enhanced G q -mediated signaling and function (Fig. 5) suggests that the function of RGS2 cannot be taken over by other G q -regulating RGS expressed in cardiac fibroblasts. Importantly, the other RGS isoforms were not subject to regulation by ANG II (Figs. 2  and 3 ), highlighting a unique susceptibility of RGS2 to regulation (21) .
Conclusions and outlook. Together, the results from the present study identify RGS2 as a novel negative regulator of ANG II-induced signaling and function in adult cardiac fibroblasts that is functionally important and highly regulated by ANG II. RGS2 upregulation after short-term ANG II stimulation might represent a brief period of negative feedback for G q -mediated events, which is diminished in myofibroblasts. RGS2 downregulation on prolonged ANG II stimulation might facilitate the development of G q -mediated fibrosis.
Therapeutic benefits of reduction of ANG II production and/or AT 1 receptor blockade in heart failure are to a significant extent derived from actions on cardiac fibroblasts and fibrotic remodeling (7) . Other G q -coupled receptors [e.g., endothelin receptors (37) ] play a role in mediating fibrosis, as well. It is therefore conceivable that RGS2 may emerge as a therapeutic target in cardiac fibroblasts (in addition to myocytes and vascular smooth muscle cells), because it mitigates signaling at the G protein level.
Further investigations are required to delineate the physiological and pathophysiological role of RGS2 in regulating fibroblast behavior and fibrosis development in vivo. To that end, studies in primary fibroblasts from normal and diseased hearts, as well as transgenic and knockout approaches, particularly during cardiac remodeling and fibrosis in response to stress, are needed. However, cardiac fibroblast-specific genetargeting experiments have been hampered by the lack of identification of suitable promoter elements (41) . In a mouse model with global RGS2 deletion, pressure overload was shown to be associated with increased fibrosis (52) . However, because RGS2 is ubiquitous with prominent expression in the vasculature and nervous system in addition to the heart, RGS2 knockout mice have a multifaceted phenotype that includes hypertension (23, 53) and an exaggerated hypertrophic response to pressure overload or myocyte-specific transgenic G␣ q expression (52) . An increase in autonomic tone has also been suggested (20) . Thus it is not possible to discern whether an increased fibrotic response observed in this model is due to the absence of RGS2 in cardiac fibroblasts or an indirect effect resulting from RGS2 deletion in other cell types. Therefore, animal models with RGS2 modifications restricted to fibro-
